Measurement of dyspnoea in the clinical rather than the research setting

Current Opinion in Supportive and Palliative Care

Volumn 2, Issue 2, 2008, Pages 95-99

  Bausewein, Claudia ^a,c   Booth, Sara ^b   Higginson, Irene J ^a,c  

^a Cicely Saunders International   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Assessment; Breathlessness; Dyspnoea; Measurement; Outcomes; Palliative care

Indexed keywords

DYSPNEA; EXERCISE TOLERANCE; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; QUESTIONNAIRE; REVIEW;

DYSPNEA; EXERCISE TOLERANCE; HEALTH STATUS INDICATORS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PALLIATIVE CARE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS;

EID: 55949110618     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e3282ffafe8     Document Type: Article

References (44)

1. Muers MF, Round CE. Palliation of symptoms in nonsmall cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 1993; 48:339-343.
2. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001; 15:287-295.
3. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1:337-344.
4. Booth S, Kelly MJ, Cox NP, et al. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med 1996; 153:1515-1518.
5. Au DH, Udris EM, Fihn SD, et al. Differences in healthcare utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 2006; 166:326-331.
6. Rocker GM, Sinuff T, Horton R, Hernandez P. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med 2007;10:783-797.
7. American Thoracic Society. Dyspnea: mechanisms, assessment and management: a consensus statement. Am J Resp Crit Care Med 1999; 159:321 -340.
8. Leupoldt A, Balewski S, Petersen S, et al. Verbal descriptors of dyspnea in patients with COPD at different intensity levels of dyspnea. Chest 2007; 132:141-147.
9. Wilcock A, Crosby V, Hughes A, et al. Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases. J Pain Symptom Manage 2002; 23:182-189.
10. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3:234-238.
11. Bausewein C, Farquhar M, Booth S, et al. Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007; 101:399-410.
12. Dorman S, ByrneA,EdwardsA.Which measurementscalesshouldweuseto measure breathlessness in palliative care? A systematic review. Palliat Med 2007; 21:177-191.
13. van der Molen B. Dyspnoea: a study of measurement instruments for the assessment of dyspnoea and their application for patients with advanced cancer. J Adv Nurs 1995; 22:948-956.
14. Ambrosino N, Porta R. Measurement of dyspnoea. Monaldi Arch Chest Dis 2001; 56:39-42.
15. Caraceni A. Evaluation and assessment of cancer pain and cancer pain treatment. Acta Anaesthesiol Scand 2001; 45:1067-1075.
16. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998; 7:200-204.
17. Wilcock A, Crosby V, Clarke D,Tattersfield A. Repeatability of breathlessness measurements in cancer patients. Thorax 1999; 54:375.
18. Morris NR, Sabapathy S, Adams L, et al. Verbal numerical scales are as reliable and sensitive as visual analog scales for rating dyspnea in young and older subjects. Respir Physiol Neurobiol 2007; 157:360-365.
19. Burdon J, Juniper E, Killian K, et al. The perception of breathlessness in asthma. Am Rev Respir Dis 1982; 126:825-828.
20. Borg GA. Psychophysical basesofperceived exertion. Med Sci SportsExerc 1982; 14:377-381.
21. Ries A. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg scale, and visual analog scale. COPD 2004;2:105-110.
22. Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci 1989; 76:277-282.
23. Carrieri-Kohlman V, Dudgeon D. Multidimensional assessmentofdyspnea. In: Booth S, Dudgeon D, editors. Dyspnoea in advanced disease. Oxford University Press; 2006. pp. 19-37.
24. Fletcher CM, Clifton M, Fry J, et al. Standardized questionnaire on respiratory symptoms. Br Med J 1960; 2:1665.
25. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581 -586.
26. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773-778.
27. GuyattGH,TownsendM,KellerJ, et al.Measuringfunctionalstatusinchronic lung disease: conclusions from a randomized control trial. Respir Med 1991; 85(Suppl B):17 -21 (discussion 33-37).
28. Lacasse Y, Wong E, Guyatt GH. A systematic overview of the measurement propertiesofthechronicrespiratoryquestionnaire.CanRespirJ1997;4:131-139.
29. Schunemann HJ, Puhan M, Goldstein R, et al. Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD 2005; 2:81 -89.
30. Guyatt G. Measuring health status in chronic airflow limitation. Eur Respir J 1988; 1:560-564.
31. Moran LA, Guyatt GH, Norman GR. Establishing the minimal number ofitems foraresponsive,valid,health-relatedqualityoflifeinstrument.JClinEpidemiol 2001; 54:571-579.
32. Dougan CF, Connell CO, Thornton E, Young CA. Development of a patient- specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS). J Neurol Sci 2000; 180:86-93.
33. Tanaka K, Akechi T, Okuyama T, et al. Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer 2000; 82:800-805.
34. Higginson IJ, CarrAJ. Measuring qualityoflife: using qualityoflifemeasuresin the clinical setting. Br Med J 2001; 322:1297-1300.
35. ChangVT,HwangSS,FeuermanM,et al.TheMemorialSymptomAssessment Scaleshortform (MSAS-SF). Cancer2000; 89:1162-1171.
36. Hearn J, Higginson IJ. Developmentand validation ofacoreoutcomemeasure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Healthcare 1999; 8:219-227.
37. Bausewein C, Fegg M, Radbruch L, et al. Validation and clinical application of the German version of the palliative care outcome scale. J Pain Symptom Manage 2005; 30:51-62.
38. Booth S, Adams L. The shuttle walking test: a reproducible method for evaluating the impactofshortness ofbreath on functional capacityin patients with advanced cancer. Thorax 2001; 56:146-150.
39. Wilcock A, Crosby V, Clarke D, et al. Reading numbers aloud: a measure of the limiting effect of breathlessness in patients with cancer. Thorax 1999; 54:1099-1103.
40. Goldberg R, Hillberg R, Reinecker L, Goldstein R. Evaluation of patients with severe pulmonary disease before and after pulmonary rehabilitation. Disabil Rehabil 2004; 26:641-648.
41. Eakin EG, Kaplan RM, Ries AL. Measurement of dyspnoea in chronic obstructive pulmonary disease. Qual Life Res 1993; 2:181 -191.
42. Heyse-Moore L, Beynon T, Ross V. Does spirometry predict dyspnoea in advanced cancer? PalliatMed 2000; 14:189-195.
43. Ahmedzai SH. Palliation of respiratory symptoms. In: Doyle D, Hanks G, MacDonald N, editors. Oxford textbook ofpalliative medicine. Oxford: Oxford University Press; 1993. pp. 583-616.
44. Wilcock A, Walker G, Manderson C, et al. Use of upper limb exercise to assess breathlessness in patients with cancer: tolerability, repeatability, and sensitivity. J Pain Symptom Manage 2005; 29:559-564.